Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK).
about
Is the Linear No-Threshold Dose-Response Paradigm Still Necessary for the Assessment of Health Effects of Low Dose Radiation?Intensified surveillance for early detection of breast cancer in high-risk patientsContralateral breast cancer after radiotherapy among BRCA1 and BRCA2 mutation carriers: a WECARE study report.Beyond mammography: new frontiers in breast cancer screening.Contribution of mammography to MRI screening in BRCA mutation carriers by BRCA status and age: individual patient data meta-analysisDiagnostic chest X-rays and breast cancer risk before age 50 years for BRCA1 and BRCA2 mutation carriers.Breast cancer risk after radiotherapy for heritable and non-heritable retinoblastoma: a US-UK study.New challenges in high-energy particle radiobiology.Breast magnetic resonance imaging: are those who need it getting it?Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: systematic review and meta-analysis.An international survey of surveillance schemes for unaffected BRCA1 and BRCA2 mutation carriers.Recommendations for breast cancer surveillance for female survivors of childhood, adolescent, and young adult cancer given chest radiation: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group.Patterns of diagnostic imaging and associated radiation exposure among long-term survivors of young adult cancer: a population-based cohort studyAdjuvant radiotherapy for primary breast cancer in BRCA1 and BRCA2 mutation carriers and risk of contralateral breast cancer with special attention to patients irradiated at younger age.Cost-effectiveness of alternating magnetic resonance imaging and digital mammography screening in BRCA1 and BRCA2 gene mutation carriersWhich screening strategy should be offered to women with BRCA1 or BRCA2 mutations? A simulation of comparative cost-effectiveness.Increased chromosomal radiosensitivity in asymptomatic carriers of a heterozygous BRCA1 mutationUsing family members to augment genetic case-control studies of a life-threatening diseaseNo strong evidence for increased risk of breast cancer 8-26 years after multiple mammograms in their 30s in females at moderate and high familial risk.MiR-34a is up-regulated in response to low dose, low energy X-ray induced DNA damage in breast cellsMagnetic resonance and computed tomography imaging of the structural and functional changes of pulmonary arterial hypertension.Breast cancer causes and treatment: where are we going wrong?Effectiveness of MR angiography for the primary diagnosis of acute pulmonary embolism: clinical outcomes at 3 months and 1 year.Analysis of chromosomal radiosensitivity of healthy BRCA2 mutation carriers and non-carriers in BRCA families with the G2 micronucleus assayManagement of genetic syndromes predisposing to gynecologic cancers.Genetic testing today.Management of women with a hereditary predisposition for breast cancer.Breast cancer screening of pregnant and breastfeeding women with BRCA mutations.The role of stress cardiac magnetic resonance in women.Should we screen BRCA1 mutation carriers only with MRI? A multicenter study.High-energy particle beam and gamma radiation exposure, familial relatedness and cancer in mice.Variation in the utilization and positivity rates of CT pulmonary angiography among emergency physicians at a tertiary academic emergency department.The Japanese Breast Cancer Society clinical practice guidelines for epidemiology and prevention of breast cancer, 2015 edition.Intuition versus cognition: a qualitative exploration of how women understand and manage their increased breast cancer risk.State of the evidence 2017: an update on the connection between breast cancer and the environmentIonising radiation: three game-changing studies for imaging in sports medicine.Management of hereditary breast and ovarian cancer.Preliminary Results of a New Auxiliary Mechatronic Near-Field Radar System to 3D Mammography for Early Detection of Breast Cancer.Integrating mammographic breast density in glandular dose calculation.Cancer risk assessment using genetic panel testing: considerations for clinical application.
P2860
Q27021419-AC3903B6-5EFA-405F-9150-1EC83A9590B0Q30392157-833E8DED-ADA8-48F3-83AD-C625AACCD653Q30410984-E97207FA-E49C-4A9D-AAF0-5F045C3B4A82Q30437422-A3FF9212-FD5D-44E3-8EFF-BF0DE52F8BA4Q31048641-15878161-1BE2-4024-AE96-7807F9A1BBF0Q33588213-E624C985-9CFB-41F7-BAE8-F919F62C49F4Q33613662-BD25B494-3EB7-4CF5-A2B9-39F091D19E6CQ33782346-333C2F7A-5B39-4ED4-8884-F8FDC20A8652Q33840185-E88603EA-825C-4C87-A415-DD3FC9010F44Q33845209-0E73677C-C731-4A3F-B9FB-31E6078498CEQ33901361-B8570AA7-D6A4-4901-9061-B93884FC76E7Q34639851-AE9795F9-D29B-4393-B9D5-F738802B51ECQ35763141-B63BEE3F-1FDD-41BB-80E4-E30203E74ECEQ36210166-0A87B71B-3E4C-4D7C-A3BD-0BF275CAABF2Q36652732-1B9F3EA7-71CF-4444-9376-BCD9A03F4E6DQ36889714-83BB9D5C-995D-41CD-89C5-AF662BEDBDF1Q36907261-85DD1E04-3DCB-440E-A16F-03181D80CADEQ36984487-AEBABFA1-C792-4E92-B81D-2457F6437C17Q37178912-DD99D4A7-3E1A-48C9-A375-1E6354355A77Q37313006-E109B047-74BD-49A9-BF5E-9A50999A34B1Q37520155-04063D50-5E96-4342-A1AE-962F69E2BA3BQ37593526-176388F8-178C-442C-9ECA-DA8D08999C9AQ37673409-263311CE-8C97-45D3-9508-BE8F44B76F91Q37720025-AC143310-221A-455B-BA26-6372F4E0EF38Q38073703-D9FAB03E-9686-43BF-B176-CAA8897D907DQ38230196-0C6A624F-AF64-4B6F-9185-B78097E54894Q38844679-C3C1FE89-A28C-4290-AA15-8F1E45E10FA8Q39110783-332E052D-936E-43DF-A123-88A001D50914Q39560578-B8A71663-72FC-4B9B-B6BF-149FB86A6A4BQ40173313-83B97355-9F5E-40BB-8600-A73B810F2EBDQ40189448-50F7F36D-002F-4EFD-9985-39EDBD7F0C62Q40221386-F0787FEA-B14A-41AB-8AFC-23BFA97519EAQ40912150-4FA4EE35-D48C-4EC4-BBC8-58148F71112BQ41143496-060DD652-3ED5-46D2-8987-681290BE4D54Q41595188-05FD9EF3-F24D-43E5-A851-75FFF7C87DEAQ44319454-FB3F9959-3450-4FE6-B908-04E13090218BQ47399250-9DE13E27-8741-4B5B-87CA-3F5C38DDA458Q48166446-870E37CB-4869-47D1-99F0-74B984F0FCADQ48500636-A456A75D-7029-402A-8D41-1FBD18C2E013Q53292592-127EA8F4-0771-45CB-A32D-0E73D6CF23FD
P2860
Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK).
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Exposure to diagnostic radiati ...... cohort study (GENE-RAD-RISK).
@ast
Exposure to diagnostic radiati ...... cohort study (GENE-RAD-RISK).
@en
Exposure to diagnostic radiati ...... ns: retrospective cohort study
@nl
type
label
Exposure to diagnostic radiati ...... cohort study (GENE-RAD-RISK).
@ast
Exposure to diagnostic radiati ...... cohort study (GENE-RAD-RISK).
@en
Exposure to diagnostic radiati ...... ns: retrospective cohort study
@nl
prefLabel
Exposure to diagnostic radiati ...... cohort study (GENE-RAD-RISK).
@ast
Exposure to diagnostic radiati ...... cohort study (GENE-RAD-RISK).
@en
Exposure to diagnostic radiati ...... ns: retrospective cohort study
@nl
P2093
P2860
P50
P356
P1433
P1476
Exposure to diagnostic radiati ...... cohort study (GENE-RAD-RISK).
@en
P2093
Anouk Pijpe
Ausrele Kesminiene
Catherine Noguès
Christine Lasset
David Goldgar
Flora E van Leeuwen
Isabelle Thierry-Chef
P2860
P356
10.1136/BMJ.E5660
P407
P50
P577
2012-09-06T00:00:00Z